Effect of adding docetaxel to androgen-deprivation therapy in patients with high-risk prostate cancer with rising prostate-specific antigen levels after primary local therapy: a randomized clinical trial
Nom du journal : JAMA Oncol
Année : 2019
Volume : 5
Page de départ : 623
Page de fin : 632